Chinese prosecutors charge a British investigator and his American wife with illegally obtaining private information in a case that is seen as key to a bribery investigation against GlaxoSmithKline. Sarah Toms reports.

▲ Hide Transcript

▶ View Transcript

A British businessman and his American wife stand trial at this court in Shanghai.
Their son arrives to hear the charges against them of illegally trafficking personal information.
Peter Humphrey has previously apologised on state television for breaking any Chinese law.
The couple ran a risk consultancy firm in China, helping foreign companies navigate the country's notoriously corrupt corporate system.
They were investigating allegations that British drugs giant GlaxoSmithKline was paying huge bribes to doctors and health officials to boost sales and raise prices.
At the start of the trial prosecutors accused them of obtaining more then 200 items of private data and reselling it to foreign corporations, including GaxoSmithKline.
Their arrest came shortly after Humphrey delivered his report to GSK.
Humphrey will almost certainly be found guilty by China's communist party controlled court system. The charge that carries a maximum sentence of three years.
And this trial only serves to highlight the obstacles foreign companies face in China's murky business world but also the lack of independent recourse when things go badly wrong.

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products: